Preclinical Pharmacokinetic Interaction and Histopathological Analyses of Hedyotis diffusa on Sorafenib in Rats

[Image: see text] Sorafenib is one of the most effective target therapeutic agents for patients with late-stage hepatocellular carcinoma. To seek possible alternative adjuvant agents to enhance the efficacy and improve the side effect of sorafenib, Hedyotis diffusa, one of the most prescribed phytom...

Descripción completa

Detalles Bibliográficos
Autores principales: Ting, Chin-Tsung, Cheng, Yung-Yi, Tsai, Tung-Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860071/
https://www.ncbi.nlm.nih.gov/pubmed/33553923
http://dx.doi.org/10.1021/acsomega.0c05461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7860071/
https://www.ncbi.nlm.nih.gov/pubmed/33553923
http://dx.doi.org/10.1021/acsomega.0c05461

Ejemplares similares